Catalyst Wire Dossier Catalyst Wire Dossier

H5N1 influenza vaccine (post-H5N2 study)

H5N1 influenza vaccine following H5N2 exposure
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H5N1 influenza vaccine (post-H5N2 study), covering 2019-02-18 to 2019-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity of H5N1 Vaccine Following H5N2 [Phase 2]

See pricing